Synthetic Biology in Action: Developing a Drug Against MDR-TB

Indian Journal of Microbiology

Volumn 54, Issue 4, 2014, Pages 369-375

  Saxena, Anjali ^a   Mukherjee, Udita ^a   Kumari, Rashmi ^a   Singh, Priya ^a   Lal, Rup ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

24 desmethylrifamycin; Multidrug resistant Mycobacterium tuberculosis; Rifampicin; Tuberculosis

Indexed keywords

MYCOBACTERIUM TUBERCULOSIS;

EID: 84918838911     PISSN: 00468991     EISSN: 09737715     Source Type: Journal    
DOI: 10.1007/s12088-014-0498-0     Document Type: Review

References (19)

1. Kalia VC, Rani A, Lal S, Cheema S, Raut CP (2007) Combing databases reveals potential antibiotic producers. Expert Opin on Drug Discov 2:211–224. doi:10.1517/17460441.2.2.211
2. Purohit HJ, Cheema S, Lal S, Raut CP, Kalia VC (2007) In search of drug targets for Mycobacterium tuberculosis. Infect Disord Drug Targets 7:245–250. doi:10.2174/187152607782110068
3. Global tuberculosis report 2013-www.who.in/tb/publications/global_report/en/
4. Maggi N, Pasqalucci CR, Ballotta R, Sensi P (1966) Rifampicin: a new orally active rifamycin. Chemotherapea 11:285–292. doi:10.1159/000220462
5. Wehrli W, Knusel F, Schmid K, Staehelin, M (1968) Interaction of rifamycin with bacterial RNA polymerase. Proc Natl Acad Sci USA 61: 667–673. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC225211/?page=1)
6. Campbell EA, Korzheva N, Mustaev A, Murakami K, Nair S, Goldfarb A, Darst SA (2001) Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell 104:901–912. doi:10.1016/S0092-8674(01)00286-0
7. Kalia VC, Purohit HJ (2011) Quenching the quorum sensing system: potential antibacterial drug targets. Critical Rev Microbiol 37:121–140. doi:10.3109/1040841X.2010.532479
8. Kalia VC (2013) Quorum sensing inhibitors: an over view. Biotechnol Adv 31:224–245. doi:10.1016/j.biotechadv.2012.10.004
9. Kalia VC (2014) Microbes, antimicrobials and resistance: the battle goes on. Indian J Microbiol. 54:1–2. doi:10.1007/s12088-013-0443-7
10. Kalia VC, Wood TK, Kumar P (2014) Evolution of resistance to quorum sensing inhibitors. Microb Ecol 68:13–23. doi:10.1007/s00248-013-0316-y
11. Diacon AH, Dawson R, Bidlingmaier-Groote FV, Symons G, Venter A, Donald PR, Niekerk CV, Everitt D, Winter H, Becker P, Mendel CM, Spigelman MK (2012) 14-Day bactericidal activity of PA-824, bedaquiline, pyrazinamide and moxifloxacin combinations: a randomized trial. Lancet 380:986–993. doi:10.1016/S0140-6736(12)61080-0
12. August PR, Tang L, Yoon YJ, Ning S, Müller R, Yu TW, Taylor M, Hoffmann D, Kim CG, Zhang X, Hutchinson CR, Floss HG (1998) Biosynthesis of the ansamycin antibiotic rifamycin: deductions from the molecular analysis of the rif biosynthetic gene cluster of Amycolatopsis mediterranei S699. Chem Bio 5:69–79. doi:10.1016/S1074-5521(98)90141-7
13. Lal R, Khanna R, Dhingra N, Khanna M, Lal S (1998) Development of an improved cloning vector and transformation system in Amycolatopsis mediterranei (Nocardia mediterranei). J Antibiot (Tokyo) 51:161–169. doi:10.7164/antibiotics
14. Lal R (1999) Cloning vector and the process for the preparation thereof. US Patent US00598560A
15. Khanna M, Dua M, Lal R (1998) Selection of suitable marker genes for the development of cloning vectors and electroporation in different strains of Amycolatopsis mediterranei. Microbiol Res 153:205–211. doi:10.1016/S0944-5013(98)80002-5
16. Lal R, Kumari R, Kaur H, Khanna R, Dhingra N, Tuteja D (2000) Regulation and manipulation of the gene clusters encoding type-I PKSs. Trends Biotechnol 18:264–274. doi:10.1016/S0167-7799(00)01443-8
17. Tuteja D, Dua M, Khanna R, Dhingra N, Khanna M, Kaur H, Saxena D, Lal R (2000) The importance of homologous recombination in the generation of large deletions in hybrid plasmids in Amycolatopsis mediterranei. Plasmid 43:1–11. doi:10.1006/plas.1999.1426
18. Dhingra G, Kumari R, Bala S, Majumdar S, Malhotra S, Sharma P, Lal S, Cullum J, Lal R (2003) Development of cloning vectors and transformation methods for Amycolatopsis. J Ind Microbiol Biotechnol 30:195–204. doi:10.1007/s10295-003-0040-6
19. Nigam A, Almabruk KH, Saxena A, Jongtae Y, Mukherjee U, Kaur H, Kohli P, Kumari R, Singh P, Zakharov LN, Singh Y, Mahmud T, Lal R (2014) Modification of rifamycin polyketide backbone leads to improved drug activity against rifampicin resistant Mycobacterium tuberculosis. J Biol Chem 289:21142–21152. doi:10.1074/jbc.M114.572636